BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
5 hedge funds and large institutions have $32K invested in Biostar Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$16K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$5K |
Top Sellers
| 1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$11K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $16K | 12,482 | +12,482 | New |
|
|
2
Acadian Asset Management
Boston,
Massachusetts
| $11K | 8,898 | -2,566 | -22% |
|
|
3
UBS Group
Zurich,
Switzerland
| $5K | 3,634 | +2,446 | +206% |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 1 | -400 | -100% |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| – | – | -39 | Closed |
|
6
Morgan Stanley
New York
| $0 | 24 | – | – |
|